DOCSLIB.ORG

Calcinosis Cutis: a Case Report and Review

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Journal of the American Osteopathic College of Dermatology Journal of the American Osteopathic College of Dermatology 2009-2010 AOCD Officers President: Leslie Kramer, DO, FAOCD President-Elect: Bradley Glick, DO, FAOCD First Vice-President: James Towry, DO, FAOCD Second Vice-President: Karen Neubauer, DO, FAOCD Third Vice-President: David Grice, DO, FAOCD Secretary-Treasurer: Jere Mammino, DO, FAOCD Immediate Past President: Marc Epstein, DO, FAOCD Executive Director: Marsha Wise Trustees: Celeste Angel, DO, FAOCD Editors Alpesh Desai, DO, FAOCD Jay S. Gottlieb, DO Mark Kuriata, DO, FAOCD Jon Keeling, DO Rick Lin, DO, FAOCD Andrew Racette, DO, FAOCD Suzanne Rozenberg, DO, FAOCD Sponsors: Global Pathology Laboratory JAOCD Founding Sponsor Medicis JAOCD Founding Sponsor Galderma Ranbaxy Intendis AOCD • 1501 E. Illinois • Kirksville, MO 63501 800-449-2623 • FAX: 660-627-2623 www.aocd.org JAOCD Founding Sponsor COPYRIGHT AND PERMISSION: written permission must be obtained from the Journal of the American Osteopathic College of Dermatology for copying or reprinting text of more than half page, tables or figures. Permissions are normally granted contingent upon similar permission from the author(s), inclusion of acknowledgement of the original source, and a payment of $15 per page, table or figure of reproduced material. Permission fees are waived for authors wishing to reproduce their own articles. Request for permission should be directed to JAOCD c/o AOCD PO Box 7525 Kirksville, MO 63501 Copyright 2003 by the Journal of the American Osteopathic College of Dermatology Printed by: The Dimensional Group, Mason City, IA 50401 Proofreading: Julia Layton, Freelance Proofreading and Editing Journal of the American Osteopathic College of Dermatology VOLUME 20, NUMBER 1 JUNE 2011 JOURNAL OF THE AMERICaocdAN OSTEOPATHIC COLLEGE OF DERMATOLOGY CONTENTS JAOCD Editors ...............................................................................................................................................................................................4 Letter from the Executive Director................................................................................................................................................................5 Letter from the JAOCD Editors .....................................................................................................................................................................6 Letter from the President ...............................................................................................................................................................................7 Calcinosis Cutis: A Case Report and Review ................................................................................................................................................8 Michael Kassardjian, MSIV,* Helia Eragi, D.O.,** Arthur Salibian, M.D.,*** Navid Nami, D.O.**** Eccrine Spiradenoma: Not Just Another Painful Nodule ..........................................................................................................................11 Yekaterina Kleydman, DO,* Michael Kassardjian, OMS IV,** Cindy Hoffman, DO,*** Charles A. Gropper, MD**** Goltz-syndrome Patient with Condyloma: Case Report and Review .......................................................................................................16 Chris Weyer, D.O.,* Ben Nasman, MS4,** Mike Morgan, M.D.,*** Lloyd Cleaver, D.O., FAOCD^ Lichen Planus Pigmentosus: Case Report and Literature Review .............................................................................................................18 Michael Baze, DO, RPh,* Daniel Hurd, DO, FAOCD,** Barbara Miller, FNP*** Mycosis Fungoides with Plantar Keratoderma – A Case Report ...............................................................................................................23 Sadaf “Sabrina” Waqar, DO, MPH,* Janet Allenby, DO** Piebaldism: A Historical and Clinical Tale from Slaves to c-Kit ...............................................................................................................25 Derrick Adams, DO,* Ralph Fiore, DO, PA-C,** Annette LaCasse, DO, FAOCD*** Polypoid Giant Basal Cell Carcinoma .........................................................................................................................................................27 Laura DeStefano, DO,* Tim Ioannides, MD,** Janet Allenby, DO*** Case Report: Ulcerated Midfacial Segmental Hemangioma Treated with Surgery, Propranolol and Vascular Dye Laser .....................28 Roxanna Menendez, DO,* Ana M. Duarte, MD,** Giovanna Ciocca, MD,** Ibrahim Amjad, MD,*** Janet Allenby, DO**** Folliculotropic Mycosis Fungoides – A Case Report ..................................................................................................................................33 Sadaf “Sabrina” Waqar, DO, MPH,* Janet Allenby, DO** Elephantiasis Nostras Verrucosa..................................................................................................................................................................35 Laura DeStefano, DO,* Janet Allenby, DO** Tuberous Xanthomas in Childhood: A Case Report and an Endocrinological Perspective ....................................................................37 Carlos Gomez-Meade, D.O.,* Carley Gomez-Meade, D.O.,** Stanley Skopit, D.O., FAOCD*** Dermatitis Herpetiformis: A Case Report and Discussion ........................................................................................................................41 Michelle Bruner, DO,* Jessica Garelik, MSIV,** Michael Baze, DO, RPh,*** Steven Grekin, DO, FACOD**** Serendipity: Scar Resolution with Laser Hair Removal ............................................................................................................................45 Jonathan Stuart Crane, D.O., F.A.O.C.D.,* Mitra Hanjani, M.D.,** Ronald P. Benjamin, M.D., * Patricia Hood, P.A.-C ,*** Kelly Britt, P.A.-C,*** Charlene Snyder, P.A.-C*** Cutaneous Bronchogenic Cyst: An Unusual Presentation and Review of the Literature .........................................................................46 Janese Trimaldi, MD,1 Sudeep Gaudi, MD,2 Richard Miller, DO,3 Michael B. Morgan, MD4 An Unusual Presentation of Elastosis Perforans Serpiginosa ....................................................................................................................48 Ali Banki, D.O.,* Hyunhee Park, D.O.,** Cindy Hoffman, D.O.*** Nail Matrix Melanoma A Case Report and Review of the Literature .......................................................................................................50 Donna D. Tran, MSIII,* Patrick Keehan, D.O.,** Bill V. Way, D.O., FAOCD*** Erythema Gyratum Repens-like Psoriasis ..................................................................................................................................................56 Jerome Obed, D.O.,* Eli Piatigorsky, D.O.,** Tracy Favreau, D.O.*** Facial Linear Morphea in Childhood A Case Report and Discussion .......................................................................................................58 Amy Spizuoco, DO,* Yoon Cohen, OMS III,** Michelle Jeffries, DO,*** Stephen Kessler, DO, FAOCD,**** Ronald Hansen, MD***** Brooke-Spiegler Syndrome Presenting with Multiple Trichoepitheliomas: A Case Report .....................................................................60 Chris Buatti, D.O,* Ryan Stevenson, MSIV,** Brian Parks, D.O.,** Kimball Silverton, D.O*** Newborn with Nonblanchable Rash ...........................................................................................................................................................62 David A. Kasper, DO, MBA,* Shannon Buck, BS,** Kimball Silverton, DO*** Painful Subcutaneous Nodules: An Initial, Abrupt Presentation of a Metastatic Carcinoma of Unknown Primary Origin ................65 Adriana Abuchar, MD,* Magalys Vitiello, MD,** Araceli Sánchez-Gilo, MD,*** Clara Milikowski, MD,**** Francisco A. Kerdel, BSc, MBBS***** Sweet’s Syndrome: A Case Presentation and Literature Review ................................................................................................................67 Joanna Izabela Sadowska, D.O., M.H.S.,* Robert A. Norman, D.O., M.P.H.** EDITOR-IN-CHIEF FOUNDING EDITOR CO-EDITOR JAY GOTTLIEB, DO, JON KEELING, DO, MIRAMAR, FL LEXINGTON, KY ASSOCIATE EDITORS Sami Abbasi, DO Jonathan Crane, DO Michael Krutchik, DO Tony Nakhla, DO Brownstown, MI Wilmington, NC Palm Harbor, FL Orange County, CA Daniel Abraham, Matthew Doppelt, DO Jocelyn LaRocque, DO Navid Nami, DO DO Jacksonville, NC Knoxville, TX Charlotte, NC Newport Beach, CA Brad Abrams, DO Merrick Elias, DO Matt Leavitt, DO Shaheen Oshtory, DO Sarasota, FL Delray Beach, FL Maitland, FL San Francisco, CA Derrick Adams, DO Brad Glick, DO Mark Lebwohl, MD Dimitria Papadopoulos, DO Red Bluff, CA Margate, FL New York, NY Bellmore, NY Marcy Alvarez, DO Marcus Goodman, DO Angela Leo, DO John Perrotto, DO Miami, FL Roswell, GA New York, NY West Palm Beach, FL Kevin Belasco, DO Melinda Greenfield, DO Scott Lim, DO Stephen Purcell, DO Milwaukee, WI Albany. GA Erie, PA Allentown, PA Brett Bender, DO Denise Guevara, DO Rick Lin, DO Andrew Racette Farmington Hill, MI Weston, FL McAllen, TX Phoenix, AZ Andrew Hanly, MD Deborah Longwill, DO Richard Rudnicki, DO Aaron Bruce, DO Miami, FL Miami, FL Mesquite, TX Loveland, CO Joel Harris, DO Chava Lustig, DO Amara Sayed, DO Jennifer Bucci, DO Madison Heights,
Recommended publications
  • Evicore Pediatric PVD Imaging Guidelines

    Evicore Pediatric PVD Imaging Guidelines

    CLINICAL GUIDELINES Pediatric Peripheral Vascular Disease (PVD) Imaging Guidelines Version 1.0 Effective January 1, 2021 eviCore healthcare Clinical Decision Support Tool Diagnostic Strategies: This tool addresses common symptoms and symptom complexes. Imaging requests for individuals with atypical symptoms or clinical presentations that are not specifically addressed will require physician review. Consultation with the referring physician, specialist and/or individual’s Primary Care Physician (PCP) may provide additional insight. CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five digit codes, nomenclature and other data are copyright 2020 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in the CPT® book. AMA does not directly or indirectly practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein. © 2020 eviCore healthcare. All rights reserved. Pediatric PVD Imaging Guidelines V1.0 Pediatric Peripheral Vascular Disease (PVD) Imaging Guidelines Procedure Codes Associated with PVD Imaging 3 PEDPVD-1: General Guidelines 5 PEDPVD-2: Vascular Anomalies 10 PEDPVD-3: Vasculitis 15 PEDPVD-4: Disorders of the Aorta and Visceral Arteries 19 PEDPVD-5: Infantile Hemangiomas 25 ______________________________________________________________________________________________________ ©2020 eviCore healthcare. All Rights Reserved. Page 2 of
  • PNWD Talk 2016

    PNWD Talk 2016

    Best Cases OHSU Kelly Griffith-Bauer, MD Case 1 •Inpatient consult: Possible vasculitis •HPI: 51 y/o gentleman with h/o COPD, recent pneumonia with 3 month history of ulcers on the R foot, unintentional 30lb weight loss •Epistaxis and tongue ulcer Physical Exam Physical Exam Histology •Neutrophilic Vasculitis involving small to medium sized vessels, as seen on step level sections through the entire tissue segment. Case 1 •Elevated ESR, +c-ANCA, cavitary lung mass Diagnosis: Wegener’s Granulomatosis • AKA granulomatosis with polyangiitis (GPA) • Granulomatous inflammation usually involving the upper and lower respiratory tract and focal necrotizing glomerulitis. • Small and medium-sized (“mixed”) vasculitis • Predominant ANCA type/antigen – C/PR3 90%, P/MPO 10% • Findings include palpable purpura, friable gums, Palisaded neutrophilic granulomatous dermatitis (PNGD) (umbilicated papules on extensors, face), subcutaneous nodules, PG-like ulcers, digital necrosis Case 2: • Presented to the OHSU dermatology clinic with an ~6 month history of painful “bumps” involving bilateral palms. • HPI: 47 y/o Native American female with a hx of Primary Biliary Cirrhosis (undergoing liver transplant work up), DM2, HTN. Physical Exam Differential for lesions of the palms/soles: • Calcinosis cutis • Corns and/or callous • Verruca Vulgaris (common and plantar warts) • Xanthoma Striatum Palmare/Plane Xanthomas • Arsenic keratoses • Gouty tophi • Acrokeratosis paraneoplastic of Bazex • Acquired keratodermas (ex, Aquatic syringeal palmar keratoderma) Histology •Nodular and interstitial granulomatous dermatitis with foam cells, consonant with xanthoma. Histology 40x CD68 Diagnosis: Xanthoma Striatum Palmare • Xanthoma striatum palmare = plane xanthomas involving the palmar creases. • Causes of xanthoma striatum palmare include: • Familial dysbetalipoproteinemia (type III). • Primary biliary cirrhosis and other cholestatic liver diseases ( Incr lipoprotein X).
  • Dermatology Eponyms – Sign –Lexicon (P)

    Dermatology Eponyms – Sign –Lexicon (P)

    2XU'HUPDWRORJ\2QOLQH Historical Article Dermatology Eponyms – sign –Lexicon (P)� Part 2 Piotr Brzezin´ ski1,2, Masaru Tanaka3, Husein Husein-ElAhmed4, Marco Castori5, Fatou Barro/Traoré6, Satish Kashiram Punshi7, Anca Chiriac8,9 1Department of Dermatology, 6th Military Support Unit, Ustka, Poland, 2Institute of Biology and Environmental Protection, Department of Cosmetology, Pomeranian Academy, Slupsk, Poland, 3Department of Dermatology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan, 4Department of Dermatology, San Cecilio University Hospital, Granada, Spain, 5Medical Genetics, Department of Experimental Medicine, Sapienza - University of Rome, San Camillo-Forlanini Hospital, Rome, Italy, 6Department of Dermatology-Venerology, Yalgado Ouédraogo Teaching Hospital Center (CHU-YO), Ouagadougou, Burkina Faso, 7Consultant in Skin Dieseases, VD, Leprosy & Leucoderma, Rajkamal Chowk, Amravati – 444 601, India, 8Department of Dermatology, Nicolina Medical Center, Iasi, Romania, 9Department of Dermato-Physiology, Apollonia University Iasi, Strada Muzicii nr 2, Iasi-700399, Romania Corresponding author: Piotr Brzezin′ski, MD PhD, E-mail: [email protected] ABSTRACT Eponyms are used almost daily in the clinical practice of dermatology. And yet, information about the person behind the eponyms is difficult to find. Indeed, who is? What is this person’s nationality? Is this person alive or dead? How can one find the paper in which this person first described the disease? Eponyms are used to describe not only disease, but also clinical signs, surgical procedures, staining techniques, pharmacological formulations, and even pieces of equipment. In this article we present the symptoms starting with (P) and other. The symptoms and their synonyms, and those who have described this symptom or phenomenon. Key words: Eponyms; Skin diseases; Sign; Phenomenon Port-Light Nose sign or tylosis palmoplantaris is widely related with the onset of squamous cell carcinoma of the esophagus.
  • Early Manifestation of Calcinosis Cutis in Pseudohypoparathyroidism Type

    Early Manifestation of Calcinosis Cutis in Pseudohypoparathyroidism Type

    European Journal of Endocrinology (2005) 152 515–519 ISSN 0804-4643 CASE REPORT Early manifestation of calcinosis cutis in pseudohypoparathyroidism type Ia associated with a novel mutation in the GNAS gene Felix G Riepe, Wiebke Ahrens1, Nils Krone, Regina Fo¨lster-Holst2, Jochen Brasch2, Wolfgang G Sippell, Olaf Hiort1 and Carl-Joachim Partsch3 Department of Pediatrics, Division of Pediatric Endocrinology, Universita¨tsklinikum Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universita¨t, 24105 Kiel, Germany, 1Department of Pediatrics, Division of Pediatric Endocrinology and Diabetes, Universita¨tsklinikum Schleswig-Holstein, Campus Lu¨beck, Universita¨t zu Lu¨beck, 23538 Lu¨beck, Germany, 2Department of Dermatology, Universita¨tsklinikum Schleswig-Holstein, Campus Kiel, Christian-Albrechts-Universita¨t, 24105 Kiel, Germany and 3Children’s Hospital, Sta¨dtische Kliniken Esslingen, 73730 Esslingen a.N., Germany (Correspondence should be addressed to W G Sippell; Email: [email protected]) Abstract Objective: To clarify the molecular defect for the clinical finding of congenital hypothyroidism com- bined with the manifestation of calcinosis cutis in infancy. Case report: The male patient presented with moderately elevated blood thyrotropin levels at neonatal screening combined with slightly decreased plasma thyroxine and tri-iodothyronine concentrations, necessitating thyroid hormone substitution 2 weeks after birth. At the age of 7 months calcinosis cutis was seen and the patient underwent further investigation. Typical features of Albright’s heredi- tary osteodystrophy (AHO), including round face, obesity and delayed psychomotor development, were found. Methods and results: Laboratory investigation revealed a resistance to parathyroid hormone (PTH) with highly elevated PTH levels and a reduction in adenylyl cyclase-stimulating protein (Gsa) activity leading to the diagnosis of pseudohypoparathyroidism type Ia (PHP Ia).
  • Guide to Policy & Practice Questions

    Guide to Policy & Practice Questions

    OREGON BOARD OF CHIROPRACTIC EXAMINERS GUIDE TO POLICY & PRACTICE QUESTIONS 530 Center St NE, suite 620 Salem, OR 97301 (503) 378-5816 [email protected] Updated/Adopted: 9/17/2020 TABLE OF CONTENTS SECTION I ............................................................................................................................................................................................... 6 DEVICES, PROCEDURES, AND SUBSTANCES ............................................................................................................................... 6 DEVICES ................................................................................................................................................................ 6 BAX 3000 AND SIMILAR DEVICES................................................................................................................................................ 6 BIOPTRON LIGHT THERAPY ........................................................................................................................................................ 6 CPAP MACHINE, ORDERING ....................................................................................................................................................... 6 CTD MARK I MULTI-TORSION TRACTION DEVICE................................................................................................................... 6 DYNATRON 2000 ...........................................................................................................................................................................
  • Calcinosis Cutis

    Calcinosis Cutis

    Dermatology Online Journal UC Davis Calcinosis cutis: A rare feature of adult dermatomyositis Inês Machado Moreira Lobo, Susana Machado, Marta Teixeira, Manuela Selores Dermatology Online Journal 14 (1): 10 Department of Dermatology, Hospital Geral de Santo António, Porto, Portugal. [email protected] Abstract Dermatomyositis is an idiopathic inflammatory myopathy with characteristic cutaneous manifestations. We describe a case of a 55- year-old woman with dermatomyositis who presented with dystrophic calcinosis resistant to medical treatment. Dermatomyositis is an idiopathic inflammatory myopathy with characteristic cutaneous manifestations, including heliotrope rash, Gottron papules, periungual telangiectasias, photodistributed erythema, poikiloderma, and alopecia. Although heliotrope rash and Gottron papules are specific cutaneous features, calcinosis of the skin or muscles is unusual in adults with dermatomyositis. However, it may occur in up to 40 percent of children or adolescents [1]. Calcinosis cutis is the deposition of insoluble calcium salts in the skin. Calcinosis cutis may be divided into four categories according to the pathogenesis as follows: dystrophic, metastatic, idiopathic, and iatrogenic. In connective tissue diseases, calcinosis is mostly of the dystrophic type and it seems to be a localized process rather than an imbalance of calcium homeostasis. Calcium deposits may be intracutaneous, subcutaneous, fascial, or intramuscular. Clinical synopsis A 55-year-old woman was referred for evaluation because of multiple, firm nodules of the lateral hips since 1994. At that time, dermatomyositis was diagnosed based on cutaneous, muscular and pulmonary involvement. The nodules, gradually enlarging since 1999, have begun to cause incapacitation pain and many exude a yellowish material suggestive of calcium. She denied an inciting traumatic event.
  • Dermatological Findings in Common Rheumatologic Diseases in Children

    Dermatological Findings in Common Rheumatologic Diseases in Children

    Available online at www.medicinescience.org Medicine Science ORIGINAL RESEARCH International Medical Journal Medicine Science 2019; ( ): Dermatological findings in common rheumatologic diseases in children 1Melike Kibar Ozturk ORCID:0000-0002-5757-8247 1Ilkin Zindanci ORCID:0000-0003-4354-9899 2Betul Sozeri ORCID:0000-0003-0358-6409 1Umraniye Training and Research Hospital, Department of Dermatology, Istanbul, Turkey. 2Umraniye Training and Research Hospital, Department of Child Rheumatology, Istanbul, Turkey Received 01 November 2018; Accepted 19 November 2018 Available online 21.01.2019 with doi:10.5455/medscience.2018.07.8966 Copyright © 2019 by authors and Medicine Science Publishing Inc. Abstract The aim of this study is to outline the common dermatological findings in pediatric rheumatologic diseases. A total of 45 patients, nineteen with juvenile idiopathic arthritis (JIA), eight with Familial Mediterranean Fever (FMF), six with scleroderma (SSc), seven with systemic lupus erythematosus (SLE), and five with dermatomyositis (DM) were included. Control group for JIA consisted of randomly chosen 19 healthy subjects of the same age and gender. The age, sex, duration of disease, site and type of lesions on skin, nails and scalp and systemic drug use were recorded. χ2 test was used. The most common skin findings in patients with psoriatic JIA were flexural psoriatic lesions, the most common nail findings were periungual desquamation and distal onycholysis, while the most common scalp findings were erythema and scaling. The most common skin finding in patients with oligoarthritis was photosensitivity, while the most common nail finding was periungual erythema, and the most common scalp findings were erythema and scaling. We saw urticarial rash, dermatographism, nail pitting and telogen effluvium in one patient with systemic arthritis; and photosensitivity, livedo reticularis and periungual erythema in another patient with RF-negative polyarthritis.
  • Soft Tissue Calcification and Ossification

    Soft Tissue Calcification and Ossification

    Soft Tissue Calcification and Ossification Soft-tissue Calcification Metastatic Calcification =deposit of calcium salts in previously normal tissue (1) as a result of elevation of Ca x P product above 60-70 (2) with normal Ca x P product after renal transplant Location:lung (alveolar septa, bronchial wall, vessel wall), kidney, gastric mucosa, heart, peripheral vessels Cause: (a)Skeletal deossification 1.1° HPT 2.Ectopic HPT production (lung / kidney tumor) 3.Renal osteodystrophy + 2° HPT 4.Hypoparathyroidism (b)Massive bone destruction 1.Widespread bone metastases 2.Plasma cell myeloma 3.Leukemia Dystrophic Calcification (c)Increased intestinal absorption =in presence of normal serum Ca + P levels secondary to local electrolyte / enzyme alterations in areas of tissue injury 1.Hypervitaminosis D Cause: 2.Milk-alkali syndrome (a)Metabolic disorder without hypercalcemia 3.Excess ingestion / IV administration of calcium salts 1.Renal osteodystrophy with 2° HPT 4.Prolonged immobilization 2.Hypoparathyroidism 5.Sarcoidosis 3.Pseudohypoparathyroidism (d)Idiopathic hypercalcemia 4.Pseudopseudohypoparathyroidism 5.Gout 6.Pseudogout = chondrocalcinosis 7.Ochronosis = alkaptonuria 8.Diabetes mellitus (b) Connective tissue disorder 1.Scleroderma 2.Dermatomyositis 3.Systemic lupus erythematosus (c)Trauma 1.Neuropathic calcifications 2.Frostbite 3.Myositis ossificans progressiva 4.Calcific tendinitis / bursitis (d)Infestation 1.Cysticercosis Generalized Calcinosis 2.Dracunculosis (guinea worm) (a)Collagen vascular disorders 3.Loiasis 1.Scleroderma
  • Malignant Nodular Hidradenoma-Inguinal Region Clinically Masquerading As Squamous Cell Carcinoma: a Case Report

    Malignant Nodular Hidradenoma-Inguinal Region Clinically Masquerading As Squamous Cell Carcinoma: a Case Report

    International Journal of Research in Medical Sciences Vernekar S et al. Int J Res Med Sci. 2019 Jul;7(7):2848-2852 www.msjonline.org pISSN 2320-6071 | eISSN 2320-6012 DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20192933 Case Report Malignant nodular hidradenoma-inguinal region clinically masquerading as squamous cell carcinoma: a case report Sunita S. Vernekar, Priyadharshini Bargunam* Department of Pathology, Karnataka Institute of Medical Sciences, Hubballi, Karnataka, India Received: 24 April 2019 Accepted: 05 June 2019 *Correspondence: Dr. Priyadharshini Bargunam, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Malignant Nodular hidradenoma is an extremely rare aggressive tumour originating from eccrine sweat glands with an incidence of <.001%. So far less than 80 cases have been reported in the literature. It’s known for its local recurrence (50%) and metastasis (60%) and hence early diagnosis and radical treatment is mandatory. But differentiating it from its benign counterparts and other skin tumour mimics is challenging, due to its histopathological similarity & lack of diagnostic immunomarkers. Authors report a case of 65-year-old female who presented with a short 4-month history of rapidly growing ulceroproliferative growth in the right inguinal region with bilateral inguinal node enlargement, associated with pain and discharge. Wedge biopsy of left inguinal lymph node showed malignant cutaneous adnexal tumour deposits, which after excision was typed as malignant nodular hidradenoma.
  • Tumoral Calcinosis and Calciphylaxis Treated with Subtotal Parathyroidectomy and Sodium Thiosulphate

    Tumoral Calcinosis and Calciphylaxis Treated with Subtotal Parathyroidectomy and Sodium Thiosulphate

    CASE REPORT eISSN 2384-0293 Yeungnam Univ J Med 2016;33(1):68-71 http://dx.doi.org/10.12701/yujm.2016.33.1.68 Tumoral calcinosis and calciphylaxis treated with subtotal parathyroidectomy and sodium thiosulphate Hyunjeong Cho1, Yongjin Yi1, Eunjeong Kang1, Seokwoo Park1, Eun Jin Cho2, Sung Tae Cho3, Rho Won Chun3, Kyu Eun Lee4, Kook-Hwan Oh1 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul; 2Department of Internal Medicine, Hongseong Medical Center, Hongseong; 3Dr. Chun & Cho`s Medical Clinic & Dialysis Center; 4Department of Surgery, Seoul National University College of Medicine, Seoul, Korea Tumoral calcinosis (TC) is a condition resulting from extensive calcium phosphate precipitation, primarily in the periarticular tissues around major joints. Calciphylaxis is a fatal ischemic vasculopathy mainly affecting dermal blood vessels and subcutaneous fat. This syndrome is rare and predominantly occurs in patients with end-stage renal disease. Here, we report on a rare case involving a patient with TC complicated with calciphylaxis. Our patient was a 31-year-old man undergoing hemodialysis who presented with masses on both shoulders and necrotic cutaneous ulcers, which were associated with secondary hyperparathyroidism, on his lower legs. He underwent subtotal parathyroidectomy, and sodium thiosulfate (STS) was administered for 27 weeks. Twenty months after beginning the STS treatment course, he experienced dramatic relief of his TC and calciphylaxis. Keywords: Tumoral calcinosis; Calciphylaxis; Parathyroidectomy; Sodium thiosulphate INTRODUCTION reported to range from 0.5-3% [2]. The pathomechanisms of these two disorders are poorly understood, but believed to Calcinosis cutis is characterized by the deposition of in- be related to disturbances in mineral metabolism.
  • Clinicopathological Correlation of Acquired Hyperpigmentary Disorders

    Clinicopathological Correlation of Acquired Hyperpigmentary Disorders

    Symposium Clinicopathological correlation of acquired Dermatopathology hyperpigmentary disorders Anisha B. Patel, Raj Kubba1, Asha Kubba1 Department of Dermatology, ABSTRACT Oregon Health Sciences University, Portland, Oregon, Acquired pigmentary disorders are group of heterogenous entities that share single, most USA, 1Delhi Dermatology Group, Delhi Dermpath significant, clinical feature, that is, dyspigmentation. Asians and Indians, in particular, are mostly Laboratory, New Delhi, India affected. Although the classic morphologies and common treatment options of these conditions have been reviewed in the global dermatology literature, the value of histpathological evaluation Address for correspondence: has not been thoroughly explored. The importance of accurate diagnosis is emphasized here as Dr. Asha Kubba, the underlying diseases have varying etiologies that need to be addressed in order to effectively 10, Aradhana Enclave, treat the dyspigmentation. In this review, we describe and discuss the utility of histology in the R.K. Puram, Sector‑13, diagnostic work of hyperpigmentary disorders, and how, in many cases, it can lead to targeted New Delhi ‑ 110 066, India. E‑mail: and more effective therapy. We focus on the most common acquired pigmentary disorders [email protected] seen in Indian patients as well as a few uncommon diseases with distinctive histological traits. Facial melanoses, including mimickers of melasma, are thoroughly explored. These diseases include lichen planus pigmentosus, discoid lupus erythematosus, drug‑induced melanoses, hyperpigmentation due to exogenous substances, acanthosis nigricans, and macular amyloidosis. Key words: Facial melanoses, histology of hyperpigmentary disorders and melasma, pigmentary disorders INTRODUCTION focus on the most common acquired hyperpigmentary disorders seen in Indian patients as well as a few Acquired pigmentary disorders are found all over the uncommon diseases with distinctive histological traits.
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T

    WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).